CTRI/2021/09/036722
Not Yet Recruiting
N/A
A Clinical study of Parkinsonâ??s disease and evaluation of Unani formulations in its management.
Department of Moalejat0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereHealth Condition 2: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
- Sponsor
- Department of Moalejat
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Tremors (4\-6 Hz)
- •Rigidity\- in upper limb cogwheel type and in lower limb lead pipe type rigidity.
- •Akinesia/ Bradykinesia/ slowness in initiation of movements.
- •Hoehn and Yahr scale upto second stage.
- •Patients between 40 to 65 years of age.
- •Patient of either sex.
- •Patient willing to sign the written informed consent.
Exclusion Criteria
- •Anxiety tremors.
- •Senile tremors.
- •Thyrotoxicosis tremors.
- •Familial tremors.
- •Mentally retarded person
- •Patients having concomitant illness such as chronic renal failure, Hepatobiliary disorder, Diabetes mellitus, Hypertension and any other neurological disorders.
- •Pregnant and lactating women.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 1
A Clinical Study for the Treatment of Parkinson's Disease with Integrated Shi Shi Tonifying Kidney Pill and Xingnao Kaiqiao AcupunctureParkinson's diseaseITMCTR1900002280ShenZhen JinFangZhenLue Technology Ltd. Co.
Recruiting
N/A
Clinical observation on the treatment of Parkinson's disease with fatigue by three injectionsParkinson's disease fatigueITMCTR2200006777The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Completed
N/A
Study about perception of Parkinson's disease progression among patients with Parkinson's disease and physicians in JapaJPRN-UMIN000032542AbbVie GK210
Completed
N/A
Study on Parkinson's disease and related disorders with dopamine transporter ligand [C-11]PE2IPatients of Parkinson's disease and related disordersJPRN-UMIN000014709Tokyo Metropolitan Institute of Gerontology200
Recruiting
N/A
Profiling Parkinson’s diseaseParkinson's diseaseNL-OMON21445Amsterdam UMC, location VUmc1,515